Gemtuzumab ozogamicin plus cytarabine determines complete remission in acute myeloid leukemia refractory to a double conventional treatment: a case report

Haematologica. 2004 Jun 1;89(6 Suppl):ECR18.

Authors

Anna Mele¹, Giovanni Sparaventi, Barbara Guiducci, Giuseppina Nicolini, Francesca d'Adamo, Giuliana Leopardi, Costante Delfini, Pierpaolo Piccaluga, Giuseppe Visani

Affiliation

¹ Department of Haematology, Hospital San Salvatore, Pesaro, Italy.

PMID: 15194554

No abstract available

Publication types

Case Reports

MeSH terms

Aged
Aminoglycosides / administration & dosage
Antibodies, Monoclonal / administration & dosage
Antibodies, Monoclonal, Humanized
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Cytarabine / administration & dosage
Female
Gemtuzumab
Humans
Immunotoxins / administration & dosage
Leukemia, Myeloid, Acute / drug therapy*
Salvage Therapy
Treatment Outcome

Substances

Aminoglycosides
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Immunotoxins
Cytarabine
Gemtuzumab